PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
23-Dec-2025 IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease ACCESS Newswire
23-Dec-2025 MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics ACCESS Newswire
22-Dec-2025 Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine ACCESS Newswire
22-Dec-2025 Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery ACCESS Newswire
22-Dec-2025 How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist ACCESS Newswire
22-Dec-2025 Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings ACCESS Newswire
22-Dec-2025 CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD ACCESS Newswire
22-Dec-2025 Trump’s Marijuana Schedule III Order Launches a Federally Regulated Healthcare Sector ACCESS Newswire
22-Dec-2025 Argentina Cement Industry Report 2025: Policy Volatility, Demand Cycles, and Sustainability Push Drive Strategic Realignment - Forecast to 2029 - ResearchAndMarkets.com Businesswire
22-Dec-2025 Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast Businesswire
22-Dec-2025 Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan iPark Businesswire
22-Dec-2025 InSilicoTrials With The Jackson Laboratory Lead CARDIOVERSE, a $30M Initiative Funded by ARPA-H to Redefine Cardiac Drug Safety with Virtual Heart Models Businesswire
22-Dec-2025 Shape Memory Medical Secures EU MDR Certification for IMPEDE® Embolization Plug Product Family, Accelerating Global Innovation in Vascular Care Businesswire
22-Dec-2025 Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes Businesswire
22-Dec-2025 Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA Businesswire
22-Dec-2025 LiveForeverHealth Launches Full-Stack Hormone & Telemedicine Franchise Model ACCESS Newswire
22-Dec-2025 KalVista Pharmaceuticals Announces Approval of EKTERLY® (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema Businesswire
22-Dec-2025 The Naderi Center Announces the Rise of "Facial Harmony" as 2025's Leading Trend in Aesthetic Surgery and Dermatology ACCESS Newswire
22-Dec-2025 £25m fund for Glasgow’s health and life sciences innovators ‘is unmissable amid booming sector’ InnoScot Health
22-Dec-2025 Sannabis S.A.S., a Colombia Licensed Cannabis Operator, Addresses U.S. Marijuana Rescheduling and Potential Implications for International Medical Cannabis Travel and Trade ACCESS Newswire